Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

During the Trading Day
37.16 -0.83 / -2.18%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
37.16 0.00 / 0.00%
Volume: 8.9K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 3
Quarter 4
Quarter 1
Quarter 2
Revenue and IncomeNet Revenues2.6M77.5M57.4M11.6M
Depreciation And Amortization--129.0K141.0K165.0K
Operating ExpensesGross Income----------
General Expenses8.0M7.2M8.7M9.7M
Research And Development5.2M4.5M5.4M6.3M
Total Operating Expenses8.0M7.3M8.8M9.9M
Non-Operating ExpensesOperating Income-5.3M70.2M48.6M1.7M
Extraordinary Credit--176.0K0.00--
Extraordinary Charge-----17.0K-15.0K
Interest Expense On Debt----2.0K2.0K
Other Expenses236.0K-2.0K0.000.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.1M70.5M48.8M2.0M
Income Taxes-48.0K-28.5M-20.0M-428.0K
Net Income-5.0M42.0M28.8M2.4M
Shares To Calculate EPSShares To Calculate EPS18.6M18.6M18.7M18.7M
Shares To Calculate EPS Diluted18.6M19.3M19.3M19.3M
Earnings Per ShareEPS-$0.27$2.18$1.49$0.13
EPS Diluted-$0.27$2.18$1.49$0.13